Philips Medical Systems recalled 286 Allura Xper FD10/10 imaging systems on September 3, 2025. The recall affects models 722011, 722027, and 722005 due to potential failure of internal components. This malfunction could inhibit motorized movements, posing risks to patient safety.
Systems may not perform as intended due to the deterioration of certain internal components (the CMOS battery, hard disk drive, and/or power supply unit). If this deterioration occurs, motorized movements of the system will become unavailable. Manual movements of the stand (longitudinal, transversal and rotational for ceiling mounted systems and rotational for floor mounted systems) and table longitudinal movements remain available. Imaging (X-ray) functionality remains available.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. or your healthcare provider for instructions. Notification method: Letter
The recall involves Allura Xper FD10/10 imaging systems with product codes 722011, 722027, and 722005. The devices were distributed worldwide, including 67 units in the U.S. and 219 units internationally.
The deterioration of internal components, such as the CMOS battery, hard disk drive, and power supply unit, may cause systems to fail. While imaging capabilities remain intact, motorized movements of the system will become unavailable.
No specific incidents of injury have been reported related to this recall. However, the potential for operational failure presents a high risk to patient safety.
Stop using the affected devices immediately. Contact Philips Medical Systems Nederland B.V. or your healthcare provider for further instructions and to follow the recall process.
For more information, call Philips at 1-800-XXX-XXXX or visit their website at www.philips.com. Additional recall details can be found at the FDA website.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.